3634 results for «209»

Filter By

3634 results

Going down the road of coronary artery disease treatment: sirolimus-coated balloon and DES + DCB stent platform

16 May 2023 – From EuroPCR 2023

What better way to talk about sirolimus-coated balloons than with real-life clinical cases? In this session, study the case of a 78-year-old man with crescendo angina and inferior wall ischaemia, or a 48-year-old woman with crescendo angina, type 2 DM and anterior wall hypokinesia with mild...

Going down the road of

Complex PCI in high bleeding risk patients: adjust your strategy!

17 May 2023 – From EuroPCR 2023

With the guidance of a live case from the Clinique Pasteur in Toulouse - multivessel PCI in a patient at high bleeding risk- and the latest results from the MASTER DAPT randomized trial that enrolled patients treated exclusively with the Ultimater stent, the presenters invite us...

Complex PCI in high bleeding

EuroPCR 2023 Welcome Ceremony

16 May 2023 – From EuroPCR 2023

As we celebrate the 30th anniversary of primary PCI for STEMI this year, follow the retrospective of this major advance in interventional cardiology, before listening to William Wijns, Jean Fajadet and their guests take stock of the current STEMI care worldwide at this opening ceremony which launches...

EuroPCR 2023 Welcome

More pulses to take you further across all calcium morphologies

17 May 2023 – From EuroPCR 2023

Discover the latest insights on intravascular lithotripsy (IVL) for treating calcified lesions: explore its mechanism of action, technological advancements, and practical tips for challenging cases, including diffuse lesions, left main bifurcations, and eccentric/calcified nodules. Enhance your expertise in IVL with this concise and informative session!

More pulses to take you

Transcatheter tricuspid valve interventions

17 May 2023 – From EuroPCR 2023

Consult this session if you want to understand clinical scenarios associated with tricuspid regurgitation, to learn the state of the art in devices and indications to treat tricuspid regurgitation, and to deepen into the available evidence of outcomes of different therapies for tricuspid regurgitation.

Transcatheter tricuspid valve interventions

The future of physiology- and morphology-guided PCI is optical!

17 May 2023 – From EuroPCR 2023

Join this session to explore the advantages of a fully optical approach in optimizing percutaneous coronary intervention (PCI) with the OptoWire III physiology wire and Nipro HF-OCT catheter. Through a practical case, you'll discover the significance of coronary physiology and intravascular imaging in bifurcation PCI and...

The future of physiology-

Bifurcation PCI

17 May 2023 – From EuroPCR 2023

View these cases that revolve around bifurcation PCI and enhance your skills in managing challenging situations. Topics covered include in particular complicated bifurcation stenting as well as hybrid culotte complex strategy. Explore these cases and much more and uncover numerous other valuable insights!

Bifurcation PCI

Which valve for which patient? - Part 1: simple anatomy

17 May 2023 – From EuroPCR 2023

Explore this session to gain insights into the influence of valve design on hemodynamic performance and durability, understand its implications for risk factors associated with TAVI in bicuspid aortic valves, and grasp the relationship between valve design, implantation techniques, and the emergence of new conduction abnormalities...

Which valve for which patient? - Part 1: simple anatomy

SMT’s Hydra TAVR Valve demonstrates sustained safety, durability, and hemodynamic performance at 5 Years

19 Nov 2025

On-site computed tomography-derived fractional flow reserve to guide the management of patients with stable coronary artery disease: The TARGET randomized trial

05 Mar 2023

Mirvat Alasnag provides her take on this clinical trial presented by Yundai Chen at the American College of Cardiology Scientific Session (ACC.23/WCC).

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
On-site computed tomography-derived fractional flow reserve to guide the management of patients with stable coronary artery disease: The TARGET randomized trial

MASTER-DAPT: “the MASTER of high-bleeding risk trials”

28 Aug 2021

Marco Valgimigli (Lugano, Switzerland) presented the results of the MASTER DAPT trial on Saturday, August 28, in a Hot Line session of the ESC Congress 2021. Luis G. Ortega-Paz provides his PICOT & SWOT analysis of this study.

Luis Ortega-Paz

Author

Luis Ortega-Paz
ESC Congress 2021 - MASTER-DAPT : “the MASTER of high-bleeding risk trials”

TRISCEND II trial: Randomized comparison of transcatheter valve replacement vs. optimal medical therapy for severe tricuspid regurgitation

04 Nov 2024

Alex Sticchi provides his take on the results of the TRISCEND II trial presented by Susheel K. Kodali and Suzanne V. Arnold at TCT 2024 in Washington.

Also watch the interview with Susheel K. Kodali

Alessandro Sticchi

Author

Alessandro Sticchi
TRISCEND II trial: Randomized comparison of transcatheter valve replacement vs. optimal medical therapy for severe tricuspid regurgitation

Harmonising optimal strategy for treatment of coronary artery diseases – bleeding risk: HOST-BR

29 Mar 2025

Daniele Giacoppo and Nicola Ammirabile provide their take on the main results of the HOST-BR trial, presented by Hyo-Soo Kim at ACC.25 in Chicago.

Nicola Ammirabile

Author

Nicola Ammirabile
Daniele Giacoppo

Author

Daniele Giacoppo
Harmonising optimal strategy for treatment of coronary artery diseases – bleeding risk: HOST-BR

HOST-EXAM:10-year follow-up of clopidogrel vs aspirin monotherapy in stable CAD after PCI with drug-eluting stent

30 Mar 2026

Nicola Ryan provides her take on the 10-year follow-up of the HOST-EXAM, which was presented by Hyo-Soo Kim at ACC.26 in New Orleans.

Nicola Ryan

Author

Nicola Ryan
10-year follow-up of clopidogrel vs aspirin monotherapy in stable coronary artery disease after percutaneous coronary intervention with drug-eluting stent
Didn’t find what you were looking for?